Total Payments
$1,739
2024 Payments
$17.57
Companies
24
Transactions
110
Medicare Patients
2,431
Medicare Billing
$239,765
Payment Breakdown by Category
Food & Beverage$1,703 (97.9%)
Education$36.57 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,703 | 108 | 97.9% |
| Education | $36.57 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $254.13 | 16 | $0 (2020) |
| Amgen Inc. | $236.33 | 16 | $0 (2019) |
| TESARO, Inc. | $225.13 | 13 | $0 (2019) |
| Celgene Corporation | $197.74 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $92.07 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $88.74 | 7 | $0 (2020) |
| Pharmacyclics LLC, An AbbVie Company | $79.96 | 5 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $72.68 | 5 | $0 (2020) |
| Kyowa Kirin, Inc. | $71.18 | 5 | $0 (2019) |
| CSL Behring | $68.34 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.57 | 1 | AstraZeneca Pharmaceuticals LP ($17.57) |
| 2023 | $79.28 | 4 | CSL Behring ($44.49) |
| 2022 | $23.85 | 1 | CSL Behring ($23.85) |
| 2020 | $181.93 | 12 | Novartis Pharmaceuticals Corporation ($75.32) |
| 2019 | $737.36 | 46 | Novartis Pharmaceuticals Corporation ($125.72) |
| 2018 | $587.38 | 38 | Amgen Inc. ($139.35) |
| 2017 | $111.94 | 8 | Celgene Corporation ($25.54) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Respiratory | ||||||
| 12/11/2023 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 11/08/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 10/11/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: COVID-19 | ||||||
| 09/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Cardiovascular | ||||||
| 10/25/2022 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/10/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $16.57 | General |
| Category: Oncology | ||||||
| 03/09/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $11.22 | General |
| Category: Hematology/Oncology | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Oncology | ||||||
| 03/02/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Oncology | ||||||
| 02/25/2020 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2020 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Oncology | ||||||
| 02/12/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Oncology | ||||||
| 02/11/2020 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2020 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $12.35 | General |
| 01/21/2020 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Oncology | ||||||
| 01/10/2020 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2020 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2019 | Lilly USA, LLC | ERBITUX (Drug), CYRAMZA | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Oncology | ||||||
| 12/17/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Oncology | ||||||
| 12/17/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $11.81 | General |
| 12/16/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Oncology | ||||||
| 12/03/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Oncology | ||||||
| 11/18/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 869 | 896 | $1.0M | $85,761 |
| 2022 | 7 | 703 | 750 | $681,504 | $65,092 |
| 2021 | 6 | 385 | 484 | $226,523 | $42,675 |
| 2020 | 5 | 474 | 595 | $298,972 | $46,236 |
Total Patients
2,431
Total Services
2,725
Medicare Billing
$239,765
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 351 | 365 | $584,000 | $47,911 | 8.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 268 | 280 | $277,760 | $25,258 | 9.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 72 | 72 | $150,624 | $11,515 | 7.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 178 | 179 | $9,845 | $1,077 | 10.9% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 248 | 261 | $417,600 | $37,734 | 9.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 132 | 136 | $134,912 | $13,406 | 9.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 28 | 29 | $60,668 | $4,877 | 8.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 42 | 50 | $19,500 | $3,361 | 17.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 50 | 53 | $31,323 | $3,060 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 21 | 27 | $6,831 | $1,413 | 20.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 182 | 194 | $10,670 | $1,240 | 11.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 149 | 222 | $86,580 | $16,952 | 19.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 75 | 93 | $51,150 | $10,488 | 20.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 78 | 78 | $49,920 | $8,155 | 16.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 22 | 22 | $18,392 | $3,172 | 17.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 37 | 45 | $11,385 | $2,392 | 21.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 24 | 24 | $9,096 | $1,516 | 16.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 173 | 256 | $99,840 | $15,361 | 15.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 129 | 167 | $91,850 | $14,445 | 15.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 107 | 107 | $68,480 | $10,469 | 15.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 31 | 31 | $25,916 | $4,019 | 15.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 34 | 34 | $12,886 | $1,942 | 15.1% |
About Dr. Michael Pinell, MD
Dr. Michael Pinell, MD is a Emergency Medicine healthcare provider based in Saint Simons Island, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841267606.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Pinell, MD has received a total of $1,739 in payments from pharmaceutical and medical device companies, with $17.57 received in 2024. These payments were reported across 110 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,703).
As a Medicare-enrolled provider, Pinell has provided services to 2,431 Medicare beneficiaries, totaling 2,725 services with total Medicare billing of $239,765. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Saint Simons Island, GA
- Active Since 03/01/2006
- Last Updated 05/02/2013
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841267606
Products in Payments
- ZEJULA (Drug) $225.13
- KISQALI (Drug) $177.86
- Revlimid (Drug) $128.17
- Neulasta (Biological) $104.00
- Imbruvica (Drug) $79.96
- CALQUENCE (Drug) $74.50
- SANCUSO (Drug) $71.18
- Kcentra (Biological) $68.34
- NINLARO (Drug) $62.32
- ADCETRIS (Biological) $59.08
- Pomalyst (Drug) $58.90
- Aranesp (Biological) $54.31
- SPRYCEL (Drug) $38.38
- MEKINIST (Drug) $36.48
- Orbactiv (Drug) $31.58
- Vitrakvi (Drug) $28.80
- Kyprolis (Biological) $28.11
- Rubraca (Drug) $27.88
- Aliqopa (Drug) $26.84
- Prolia (Biological) $24.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.